0001209191-14-071540.txt : 20141126
0001209191-14-071540.hdr.sgml : 20141126
20141126165534
ACCESSION NUMBER: 0001209191-14-071540
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141124
FILED AS OF DATE: 20141126
DATE AS OF CHANGE: 20141126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Higgins Michael J
CENTRAL INDEX KEY: 0001478521
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 141254286
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS INC
STREET 2: 320 BENT STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-11-24
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001478521
Higgins Michael J
C/O IRONWOOD PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Operating Officer
Class B Common Stock
2014-11-24
4
M
0
70898
1.56
A
370898
D
Class B Common Stock
2014-11-24
4
S
0
70898
13.75
D
300000
D
Employee Stock Option (Right to Buy)
1.56
2014-11-24
4
M
0
70898
0.00
D
2016-03-14
Class B Common Stock
70898
129102
D
In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.64 to $13.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The option vests upon the earlier of (i) the issuer's achievement of certain regulatory and commercial milestones and (ii) January 1, 2016. Upon achievement of a regulatory milestone on October 24, 2011 and a commercial milestone on December 21, 2012, the option vested as to 100,000 and 50,000 shares, respectively.
/s/ Halley E. Gilbert
Attorney-in-Fact
2014-11-26